About
Technology
Issues
FAQ
Links
Official Page
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.